SysteMHC v.231201
Home Datasets
Explore
Search atlas
Non-UniProt peptides
Statistics
Atlas stats
Allele stats
PTM stats
Download Help About Update

Showing details for project SYSMHC00057



SampleID NumReplicates Organism TissueType CellType MHCAllele
SampleID NumReplicates Organism TissueType CellType MHCAllele
SYSMHC00057_20210510_A0201_SDBXC_30 2 Human HLA-A02_01
SYSMHC00057_20210510_A0201_SDBXC_FRX 3 Human HLA-A02_01
SYSMHC00057_20210604_A0201_2injections 2 Human HLA-A02_01
SYSMHC00057_20210604_A0201_3injections 3 Human HLA-A02_01
SYSMHC00057_20210604_A0201_FRX 3 Human HLA-A02_01
SYSMHC00057_A0201_FAIMS 2 Human HLA-A02_01
SYSMHC00057_A0201_FAIMS_frx 3 Human HLA-A02_01
SYSMHC00057_A0201_FRX 3 Human HLA-A02_01
SYSMHC00057_A1101_CV 4 Human HLA-A11_01
SYSMHC00057_B0702_CV 4 Human HLA-B07_02
SYSMHC00057_B4901 2 Human HLA-B49_01
SYSMHC00057_B4901_FAIMS 2 Human HLA-B49_01
SYSMHC00057_B5301 2 Human HLA-B53_01
SYSMHC00057_B5301_FAIMS 2 Human HLA-B53_01
SYSMHC00057_HLA_A0201 2 Human HLA-A02_01
SYSMHC00057_MEL_13240-002 2 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02
SYSMHC00057_MEL_13240-002_FAIMS 2 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02
SYSMHC00057_MEL_13240-002_frx 6 Human HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02
SYSMHC00057_MEL_13240-011_Exploris 2 Human HLA-A66_01,HLA-A01_03,HLA-B08_01,HLA-C07_01
SYSMHC00057_MEL_13240-011_FAIMS_Exploris 2 Human HLA-A66_01,HLA-A01_03,HLA-B08_01,HLA-C07_01
SYSMHC00057_MEL_13240-011_FRX_Exploris 3 Human HLA-A66_01,HLA-A01_03,HLA-B08_01,HLA-C07_01
SYSMHC00057_MEL_13240-011_FRX_FAIMS_Exploris 3 Human HLA-A66_01,HLA-A01_03,HLA-B08_01,HLA-C07_01
SYSMHC00057_MEL_13240-011_FRX_FAIMS_Lumos 3 Human HLA-A66_01,HLA-A01_03,HLA-B08_01,HLA-C07_01
SYSMHC00057_MEL_13240-011_FRX_Lumos 3 Human HLA-A66_01,HLA-A01_03,HLA-B08_01,HLA-C07_01
SYSMHC00057_RCC_16097-104_tumorprimary_frx 3 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097-105_tumor_FAIMS 2 Human HLA-A01_01,HLA-B08_01,HLA-C07_01
SYSMHC00057_RCC_16097-105_tumor_FAIMS_frx 3 Human HLA-A01_01,HLA-B08_01,HLA-C07_01
SYSMHC00057_RCC_16097-105_tumor_frx 3 Human HLA-A01_01,HLA-B08_01,HLA-C07_01
SYSMHC00057_RCC_16097_101_tumor 2 Human HLA-A01_01,HLA-A66_01,HLA-B57_01,HLA-B40_01,HLA-C06_02,HLA-C03_04
SYSMHC00057_RCC_16097_101_tumor_FAIMS 2 Human HLA-A01_01,HLA-A66_01,HLA-B57_01,HLA-B40_01,HLA-C06_02,HLA-C03_04
SYSMHC00057_RCC_16097_101_tumor_frx 7 Human HLA-A01_01,HLA-A66_01,HLA-B57_01,HLA-B40_01,HLA-C06_02,HLA-C03_04
SYSMHC00057_RCC_16097_102_tumor 2 Human HLA-A02_01,HLA-B38_01,HLA-B35_03,HLA-C12_03
SYSMHC00057_RCC_16097_102_tumor_FAIMS 2 Human HLA-A02_01,HLA-B38_01,HLA-B35_03,HLA-C12_03
SYSMHC00057_RCC_16097_102_tumor_FRX 4 Human HLA-A02_01,HLA-B38_01,HLA-B35_03,HLA-C12_03
SYSMHC00057_RCC_16097_102_tumor_FRXFAIMS 4 Human HLA-A02_01,HLA-B38_01,HLA-B35_03,HLA-C12_03
SYSMHC00057_RCC_16097_104_Metastasis_FAIMS 2 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097_104_Metastasis_FAIMS_frx 6 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097_104_Metastasis_frx 3 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097_104_metastasis 2 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097_104_tumorprimary 2 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097_104_tumorprimary_FAIMS 2 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01
SYSMHC00057_RCC_16097_104_tumorprimary_FAIMS_frx 3 Human HLA-A01_01,HLA-A30_01,HLA-B08_01,HLA-B13_02,HLA-C06_02,HLA-C07_01



Detailed view of sample SYSMHC00057_MEL_13240-002_frx



ID SampleID RawFileName Organism Process Tissue Type Cell Type Culture Conditions Disease State Comments MHCClass MHCAllele PubMed ID Peptide Isolation Method Antibody Mass Spectrometer LC System iRT Peptides Acquisition Mode Fragmentation Method Gradient Gradient Length Flow Rate Replicate Number
ID SampleID RawFileName Organism Process Tissue_Type Cell_Type Culture_Conditions Disease_State Comments MHCClass MHCAllele PubMed_ID Peptide Isolation_Method Antibody Mass_Spectrometer LC_System iRT_Peptides Acquisition_Mode Fragmentation_Method Gradient Gradient_Length Flow_Rate Replicate_Number
SYSMHC00057 SYSMHC00057_MEL_13240-002_frx YY20190422_AA_Pat2_SDB_fxn3_02.raw Human In vitro Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 1
SYSMHC00057 SYSMHC00057_MEL_13240-002_frx YY20190422_AA_Pat2_SDB_fxn3_01.raw Human In vitro Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 2
SYSMHC00057 SYSMHC00057_MEL_13240-002_frx YY20190422_AA_Pat2_SDB_fxn1_02.raw Human In vitro Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 3
SYSMHC00057 SYSMHC00057_MEL_13240-002_frx YY20190422_AA_Pat2_SDB_fxn2_01.raw Human In vitro Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 4
SYSMHC00057 SYSMHC00057_MEL_13240-002_frx YY20190422_AA_Pat2_SDB_fxn2_02.raw Human In vitro Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 5
SYSMHC00057 SYSMHC00057_MEL_13240-002_frx YY20190422_AA_Pat2_SDB_fxn1_01.raw Human In vitro Melanoma Melanoma adherent Melanoma class I HLA-A02_01,HLA-A24_02,HLA-B15_01,HLA-B44_02,HLA-C05_01,HLA-C07_02 34391888 native Immunoaffinity W6/32 Q-Exactive EasyNanoLC 1200 no DDA HCD 6